Inhibition by somatostatin of secretin-stimulated pancreatic secretion in man: a study with pure pancreatic juice
- PMID: 189382
Inhibition by somatostatin of secretin-stimulated pancreatic secretion in man: a study with pure pancreatic juice
Abstract
The action of somatostatin on compostition and flow rate of pure pancreatic juice obtained by endoscopic cannulation of the main pancreatic duct was evaluated in 5 healthy volunteers. Synthetic secretin (0.06 CU/kg-h) was intravenously infused throughout the 80-min study. Bicarbonate concentrations in pancreatic juice achieved constant levels (117 +/- 3 muEq/ml) after 10 min, whereas a steady state of juice flow (7.3 +/- 1.4 ml/5 min) was attained after 15 min of secretin infusion. In the third 20-min period, cyclic somatostatic (5 mug/kg-h i.v.) was given, leading to a decrease in pancreatic flow rate by 47% after 10 min, and by 67% after 15 min of somatostatin administration. Alrady 5 min after the infusion of somatostatin had been discontinued, pancreatic flow rate gradually recovered; presomatostatin levels, however, were not reached within 20 min. Cyclic AMP varied roughly in accordance with bicarbonate concentrations, whereas the chloride concentrations were reciprocally related. Bicarbonate, sodium, potassium, protein, and cyclic GMP concentrations did not change substantially due to somatostatin.
Similar articles
-
Bicarbonate and cyclic AMP content of pure human pancreatic juice in response to graded doses of synthetic secretin.Gastroenterology. 1976 Apr;70(4):533-6. Gastroenterology. 1976. PMID: 176080
-
Further studies on the effect of cholecystokinin and secretin on the content of cyclic AMP, cyclic GMP, protein and calcium in pure pancreatic juice of dogs.Z Gastroenterol. 1980 May;18(5):265-73. Z Gastroenterol. 1980. PMID: 6254284
-
The effect of moderate sedation on exocrine pancreas function in normal healthy subjects: a prospective, randomized, cross-over trial using the synthetic porcine secretin stimulated Endoscopic Pancreatic Function Test (ePFT).Am J Gastroenterol. 2005 May;100(5):1161-6. doi: 10.1111/j.1572-0241.2005.41386.x. Am J Gastroenterol. 2005. PMID: 15842594 Clinical Trial.
-
Effect of low dose secretin and caerulein on pure pancreatic bicarbonate secretion and plasma secretin in man.Acta Hepatogastroenterol (Stuttg). 1979 Dec;26(6):478-81. Acta Hepatogastroenterol (Stuttg). 1979. PMID: 549430
-
Effect of somatostatin on exocrine pancreatic function.Nutr Rev. 1977 Aug;35(8):210-2. doi: 10.1111/j.1753-4887.1977.tb06602.x. Nutr Rev. 1977. PMID: 197456 Review. No abstract available.
Cited by
-
Effect of somatostatin 14 on pure human pancreatic secretion.Dig Dis Sci. 1987 Oct;32(10):1065-70. doi: 10.1007/BF01300189. Dig Dis Sci. 1987. PMID: 2888607
-
A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man.J Endocrinol Invest. 1980 Jul-Sep;3(3):279-82. doi: 10.1007/BF03348276. J Endocrinol Invest. 1980. PMID: 6159391 Clinical Trial.
-
Transepithelial bicarbonate secretion: lessons from the pancreas.Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a009571. doi: 10.1101/cshperspect.a009571. Cold Spring Harb Perspect Med. 2012. PMID: 23028131 Free PMC article.
-
Tissue specificity of DNA damage response and tumorigenesis.Cancer Biol Med. 2019 Aug;16(3):396-414. doi: 10.20892/j.issn.2095-3941.2019.0097. Cancer Biol Med. 2019. PMID: 31565474 Free PMC article.
-
Effect of intravenous infusion of somatostatin on gastric, pancreatic and biliary secretion in the rat.Gastroenterol Jpn. 1978;13(3):190-6. doi: 10.1007/BF02773663. Gastroenterol Jpn. 1978. PMID: 357240